ALFA Finder| Revenue growth | 19.5% YoY for FY26 |
|---|---|
| Margins | EBITDA margins 41.4% (FY26), ahead of 40% guidance. |
| Demand visibility | Strong; driven by wellness and newer markets. |
| Management confidence | High; outperforming long-term 15% growth guidance. |
Growth
FY26 revenue grew 19.5% YoY; PAT grew 20.3% YoY to ₹1,730 Mn. Q4 EBITDA margins reached 43.5%.
Outlook
Guided for 4-5 hubs and 10-12 spokes in FY27. Setting up automated lab in Hyderabad.
Risks
Competition in diagnostic sector; integration of acquisitions; reliance on core Hyderabad/Telangana markets.
Earnings Call filed with BSE, NSE: VIJAYA. Summary written with AI assistance from the document.
Vijaya Diagnostic Centre Ltd: key numbers
- Share price
- ₹1,422.70
- Market cap
- ₹14,653 Cr
- Revenue (annual)
- ₹814.2 Cr
- Net profit (annual)
- ₹173.0 Cr
- P/E (TTM)
- 71.9×Sector 54.5×
- Promoter holding
- 52.46%-0.05% QoQ
- FII holding
- 10.67%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Vijaya Diagnostic Centre Ltd
All →Vijaya Diagnostic Centre Earnings Call Transcript: Key Takeaways
Vijaya Diagnostic delivered strong Q2 growth, leveraging operating leverage and CGHS tariff revisions to expand margins significantly despite aggressive network expansion.
- Call
- Guides 20% growth
Vijaya Diagnostic Centre Investor Presentation: Key Takeaways
Q2 FY27 revenue ₹2,554 Mn (+26.7%), EBITDA ₹1,128 Mn (44.1% margin), PAT ₹595 Mn (23.3%). Strategy: hub-and-spoke densification, Bengaluru/Hyderabad hubs, Guwahati entry.
Vijaya Diagnostic Centre Results Update
Vijaya Diagnostic's Q2 FY27 press release reports revenue up 26.7% and PAT up 37.4% year-on-year. It also notes an agreement to acquire Arya Wellness Centre in Guwahati.
Vijaya Diagnostic Centre Management Change
Vijaya Diagnostic Centre appointed Rahul Jain as Company Secretary and Compliance Officer, designated KMP, effective November 03, 2026. The appointment follows the Nomination and Remuneration Committee's recommendation.
Vijaya Diagnostic Centre Q2 FY27 Results: Net Profit ₹59.5 Cr, Up 37.4% YoY
Vijaya Diagnostic Centre Ltd reported revenue from operations of ₹255.4 Cr (+26.7% YoY) and net profit of ₹59.5 Cr (+37.4% YoY) for Q2 FY27.
- Key figure
- Net profit ₹59.5 Cr · +37.4% YoY
Vijaya Diagnostic Centre Board Meeting Date
Vijaya Diagnostic Centre scheduled a board meeting for 3 Nov 2026 to approve unaudited Q1 and H1 FY27 results. No financial figures or material decisions are disclosed in this notice.